Search Results - "Kathrin Blagec"

Neural sentence embedding models for semantic similarity estimation in the biomedical domain by Blagec, Kathrin, Xu, Hong, Agibetov, Asan, Samwald, Matthias

“…Neural network based embedding models are receiving significant attention in the field of natural language processing due to their capability to effectively…”
Get full text

Mapping global dynamics of benchmark creation and saturation in artificial intelligence by Ott, Simon, Barbosa-Silva, Adriano, Blagec, Kathrin, Brauner, Jan, Samwald, Matthias

“…Benchmarks are crucial to measuring and steering progress in artificial intelligence (AI). However, recent studies raised concerns over the state of AI…”
Get full text

Fast and scalable neural embedding models for biomedical sentence classification by Agibetov, Asan, Blagec, Kathrin, Xu, Hong, Samwald, Matthias

“…Biomedical literature is expanding rapidly, and tools that help locate information of interest are needed. To this end, a multitude of different approaches for…”
Get full text

A curated, ontology-based, large-scale knowledge graph of artificial intelligence tasks and benchmarks by Blagec, Kathrin, Barbosa-Silva, Adriano, Ott, Simon, Samwald, Matthias

“…Research in artificial intelligence (AI) is addressing a growing number of tasks through a rapidly growing number of models and methodologies. This makes it…”
Get full text

Digital health understanding and preparedness of medical students: a cross-sectional study by Baumgartner, Martin, Sauer, Christoph, Blagec, Kathrin, Dorffner, Georg

“…Digitalisation is changing all areas of our daily life. This changing environment requires new competences from physicians in all specialities. This study…”
Get full text

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available by Samwald, Matthias, Xu, Hong, Blagec, Kathrin, Empey, Philip E, Malone, Daniel C, Ahmed, Seid Mussa, Ryan, Patrick, Hofer, Sebastian, Boyce, Richard D

“…Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to implement and more cost-effective than reactive pharmacogenomic testing if a…”
Get full text

Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study by Blagec, Kathrin, Romagnoli, Katrina M, Boyce, Richard D, Samwald, Matthias

“…Background. Pharmacogenomic testing has the potential to improve the safety and efficacy of pharmacotherapy, but clinical application of pharmacogenetic…”
Get full text

An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care by Miñarro-Giménez, Jose Antonio, Blagec, Kathrin, Boyce, Richard D, Adlassnig, Klaus-Peter, Samwald, Matthias

“…The development of genotyping and genetic sequencing techniques and their evolution towards low costs and quick turnaround have encouraged a wide range of…”
Get full text

Benchmark datasets driving artificial intelligence development fail to capture the needs of medical professionals by Blagec, Kathrin, Kraiger, Jakob, Frühwirt, Wolfgang, Samwald, Matthias

“…[Display omitted] Publicly accessible benchmarks that allow for assessing and comparing model performances are important drivers of progress in artificial…”
Get full text

The Importance of Gene-Drug-Drug-Interactions in Pharmacogenomics Decision Support: An Analysis Based on Austrian Claims Data by Blagec, Kathrin, Kuch, Wolfgang, Samwald, Matthias

“…While pharmacogenomic testing combined with clinical decision support has the potential to increase the safety and efficacy of medical treatments, the intake…”
Get more information

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project by Blagec, Kathrin, Koopmann, Rudolf, Crommentuijn-van Rhenen, Mandy, Holsappel, Inge, van der Wouden, Cathelijne H, Konta, Lidija, Xu, Hong, Steinberger, Daniela, Just, Enrico, Swen, Jesse J, Guchelaar, Henk-Jan, Samwald, Matthias

“…Clinical pharmacogenomics (PGx) has the potential to make pharmacotherapy safer and more effective by utilizing genetic patient data for drug dosing and…”
Get full text

Effects of Medical Device Regulations on the Development of Stand-Alone Medical Software: A Pilot Study by Blagec, Kathrin, Jungwirth, David, Haluza, Daniela, Samwald, Matthias

“…Medical device regulations which aim to ensure safety standards do not only apply to hardware devices but also to standalone medical software, e.g. mobile…”
Get more information

Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data by Samwald, Matthias, Blagec, Kathrin, Hofer, Sebastian, Freimuth, Robert R

“…Many currently available pharmacogenomic assays and algorithms interrogate a set of 'tag' polymorphisms for inferring haplotypes. We wanted to test the…”
Get full text

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries by Kathrin Blagec, Jesse J Swen, Rudolf Koopmann, Ka-Chun Cheung, Mandy Crommentuijn-van Rhenen, Inge Holsappel, Lidija Konta, Simon Ott, Daniela Steinberger, Hong Xu, Erika Cecchin, Vita Dolžan, Cristina Lucía Dávila-Fajardo, George P Patrinos, Gere Sunder-Plassmann, Richard M Turner, Munir Pirmohamed, Henk-Jan Guchelaar, Matthias Samwald, Ubiquitous Pharmacogenomics Consortium

“…BackgroundThe clinical implementation of pharmacogenomics (PGx) could be one of the first milestones towards realizing personalized medicine in routine care…”
Get full text

Towards a global IT system for personalized medicine: the Medicine Safety Code initiative by Samwald, Matthias, Minarro-Giménez, José Antonio, Blagec, Kathrin, Adlassnig, Klaus-Peter

“…The availability of pharmacogenomic data of individual patients can significantly improve physicians' prescribing behavior, lead to a reduced incidence of…”
Get more information

Towards a global IT system for personalized medicine: the Medicine Safety Code initiative by Samwald, Matthias, Minarro-Giménez, José Antonio, Blagec, Kathrin, Adlassnig, Klaus-Peter

“…The availability of pharmacogenomic data of individual patients can significantly improve physicians' prescribing behavior, lead to a reduced incidence of…”
Get more information

Deep learning models are not robust against noise in clinical text by Moradi, Milad, Blagec, Kathrin, Samwald, Matthias

“…Artificial Intelligence (AI) systems are attracting increasing interest in the medical domain due to their ability to learn complicated tasks that require…”
Get full text

An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care: e93769 by Minarro-Gimenez, Jose Antonio, Blagec, Kathrin, Boyce, Richard D, Adlassnig, Klaus-Peter, Samwald, Matthias

“…Background The development of genotyping and genetic sequencing techniques and their evolution towards low costs and quick turnaround have encouraged a wide…”
Get full text

Benchmark datasets driving artificial intelligence development fail to capture the needs of medical professionals by Blagec, Kathrin, Kraiger, Jakob, Frühwirt, Wolfgang, Samwald, Matthias

“…Journal of Bioinformatics, January 2023 Publicly accessible benchmarks that allow for assessing and comparing model performances are important drivers of…”
Get full text

A global analysis of metrics used for measuring performance in natural language processing by Blagec, Kathrin, Dorffner, Georg, Moradi, Milad, Ott, Simon, Samwald, Matthias

“…Measuring the performance of natural language processing models is challenging. Traditionally used metrics, such as BLEU and ROUGE, originally devised for…”
Get full text